ACRS – Aclaris Therapeutics Inc

Aclaris Therapeutics, Inc.

ACRS

$4.24

Name : Aclaris Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $672,515,456.00

EPSttm : -0.59

Aclaris Therapeutics, Inc.

$4.24

2.17%

$0.09

ACRS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.56

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

-0.06

EPS Last/This Y

-0.1

EPS This/Next Y

-0.09

Price

4.15

Target Price

10.75

Analyst Recom

1.15

Performance Q

-28.94

Upside

-284.8%

Beta

0.93

Ticker: ACRS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	ACRS	3.59	0.53	0.34	14261
2026-10-13	ACRS	3.45	0.53	0.00	14292
2026-10-14	ACRS	3.42	0.52	15.43	14391
2026-10-15	ACRS	3.48	0.48	1.61	14012
2026-10-16	ACRS	3.29	0.48	999.99	14009
2026-10-19	ACRS	3.47	0.47	0.00	12573
2026-10-20	ACRS	3.77	0.38	2.96	14438
2026-10-21	ACRS	3.81	0.42	0.56	15030
2026-10-22	ACRS	3.85	0.42	0.05	15150
2026-10-23	ACRS	3.76	0.42	8.32	15212
2026-10-26	ACRS	3.8	0.47	0.07	15848
2026-10-27	ACRS	3.79	0.48	0.17	16025
2026-10-28	ACRS	3.96	0.47	0.00	16583
2026-10-29	ACRS	4	0.46	0.46	16423
2026-10-30	ACRS	3.96	0.46	0.01	16491
2026-11-02	ACRS	3.79	0.46	0.08	16554
2026-11-03	ACRS	3.73	0.46	0.00	16552
2026-11-04	ACRS	3.67	0.46	0.00	16550
2026-11-05	ACRS	3.62	0.45	6.52	16775
2026-11-06	ACRS	3.9	0.44	0.29	16708
2026-11-09	ACRS	4.25	0.41	1.79	20058
2026-11-10	ACRS	4.16	0.41	28.00	20119
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	ACRS	3.60	-37.5	-	-0.64
2026-10-13	ACRS	3.45	-37.5	-	-0.64
2026-10-14	ACRS	3.38	-37.5	-	-0.64
2026-10-15	ACRS	3.48	-37.5	-	-0.64
2026-10-16	ACRS	3.29	-37.5	-	-0.64
2026-10-19	ACRS	3.48	-37.5	-	-0.64
2026-10-20	ACRS	3.48	-37.5	-	-0.64
2026-10-21	ACRS	3.77	-37.5	-	-0.64
2026-10-22	ACRS	3.85	-37.5	-	-0.64
2026-10-23	ACRS	3.75	-37.5	-	-0.64
2026-10-26	ACRS	3.80	-37.1	-	-0.65
2026-10-27	ACRS	3.78	-37.1	-	-0.65
2026-10-28	ACRS	3.97	-37.1	-	-0.65
2026-10-29	ACRS	4.00	-37.1	-	-0.65
2026-10-30	ACRS	3.96	-34.8	-	-0.64
2026-11-02	ACRS	3.78	-34.8	-	-0.64
2026-11-03	ACRS	3.73	-34.8	-	-0.64
2026-11-04	ACRS	3.67	-34.8	-	-0.64
2026-11-05	ACRS	3.63	-34.8	-	-0.64
2026-11-06	ACRS	3.90	-34.8	-	-0.64
2026-11-09	ACRS	4.25	-34.8	-	-0.64
2026-11-10	ACRS	4.15	-34.8	-	-0.63
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	ACRS	-0.82	4.86	16.38
2026-10-13	ACRS	-0.82	4.86	16.38
2026-10-14	ACRS	-0.82	4.86	16.38
2026-10-15	ACRS	-0.82	4.86	16.38
2026-10-16	ACRS	-0.82	4.86	16.38
2026-10-19	ACRS	-0.82	4.86	16.38
2026-10-20	ACRS	-0.82	4.86	16.38
2026-10-21	ACRS	-0.82	4.86	16.38
2026-10-22	ACRS	-0.82	4.86	16.38
2026-10-23	ACRS	-0.82	4.86	16.38
2026-10-26	ACRS	-0.82	4.83	16.38
2026-10-27	ACRS	-0.82	4.83	13.53
2026-10-28	ACRS	0.00	4.83	13.53
2026-10-29	ACRS	0.00	4.83	13.53
2026-10-30	ACRS	0.00	4.83	13.53
2026-11-02	ACRS	0.00	4.81	13.53
2026-11-03	ACRS	0.00	4.81	13.53
2026-11-05	ACRS	0.00	4.81	13.53
2026-11-06	ACRS	0.00	4.81	13.53
2026-11-09	ACRS	0.00	4.30	12.56
2026-11-10	ACRS	0.00	4.30	12.56
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.12

Avg. EPS Est. Current Quarter

-0.18

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

Institutional Transactions

4.3

Beta

0.93

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

78.1

Max Drawdown 5-Year %

-96.5

Target Price

10.75

P/E

Forward P/E

PEG

P/S

102.85

P/B

3.75

P/Free Cash Flow

EPS

-0.59

Average EPS Est. Cur. Y

-0.63

EPS Next Y. (Est.)

-0.72

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1244.09

Relative Volume

0.49

Return on Equity vs Sector %

-74

Return on Equity vs Industry %

-54.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

◆ ACRS Healthcare

$4.15

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

11/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

52.9

Range 1M

82.9%

Sup Dist

4.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

7/30

Estimates

0/20

Inst/Vol

5/15

Options

4/10

EPS Yr

-14%

EPS NY

-13.4%

52W%

44.8%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +159% upside

Quality

2/30

Valuation

16/30

Growth

3/25

Stability

8/10

LT Trend

0/5

Upside

+159%

Quality

ACRS — P/E HistoricalBiotechnology

Aclaris Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 69

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States. The company product pipeline includes Bosakitug (ATI-045), an anti-thymic stromal lymphopoietin monoclonal antibody in Phase 2 trial to treat moderate to severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and moderate to severe chronic obstructive pulmonary disease; ATI-2138, an potent and selective novel investigational dual inhibitor of ITK and JAK3 in Phase 2a trial for the treatment for T cell-mediated autoimmune diseases; ATI-052, a humanized anti-TSLP and anti-IL4R bispecific antibody in Phase 1b to treat various atopic, immunologic, and respiratory diseases; ATI-9494, an oral, covalent, investigational dual inhibitor of ITK and Resting Lymphocyte Kinase (TXK), and other covalent JAK-sparing ITK inhibitors to treat modulate T cell biology across various diseases; and Lepzacitinib, a soft JAK 1/3 inhibitor for the treatment of atopic dermatitis and other dermatologic conditions. Aclaris Therapeutics, Inc. was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

ACRS

Latest News

—

Caricamento notizie per ACRS…

stock quote shares ACRS – Aclaris Therapeutics Inc Stock Price stock today

news today ACRS – Aclaris Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ACRS – Aclaris Therapeutics Inc yahoo finance google finance

stock history ACRS – Aclaris Therapeutics Inc invest stock market

stock prices ACRS premarket after hours

ticker ACRS fair value insiders trading

ACRS – Aclaris Therapeutics Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ACRS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y